My dad, his ‘incurable’ disease, and hope at last
Today in Focus
00:00
Cost, Approval Pathway, and Accessibility
Josh covers likely high costs, comparisons to other gene therapies, and the regulatory route via the FDA then UK and EU approval.
Play episode from 26:09
Transcript
